FML-Neo Liquifilm Augentropfensuspension Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

fml-neo liquifilm augentropfensuspension

abbvie ag - fluorometholonum, neomycinum - augentropfensuspension - fluorometholonum 1 mg, neomycinum 3.5 mg ut neomycini sulfas, benzalkonii chloridum 0.04 mg, poly(alcohol vinylicus), dinatrii edetas, natrii chloridum, dinatrii phosphas heptahydricus corresp. phosphas 1.89 mg, polysorbatum 80, natrii hydroxidum aut acidum hydrochloridum, aqua purificata, natrii thiosulfas, ad suspensionem pro 1 ml. - infectés yeux - synthetika

FML-NEO OPH SUS Suspension Canada - français - Health Canada

fml-neo oph sus suspension

allergan inc - fluorométholone; sulfate de néomycine - suspension - 0.1%; 0.5% - fluorométholone 0.1%; sulfate de néomycine 0.5% - antibacterials